Revlimid

HaemaLogix's myeloma drug boosts responses in Revlimid combo

HaemaLogix has posted phase 2b data that show its monoclonal antibody improves response rates for multiple myeloma patients when paired with Revlimid.

James Waldron Jun 29, 2023 9:10am

Celgene on biotech hunt with Agios, Jounce in crosshairs: FT

Apr 9, 2018 4:08am